| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 83.22M | — |
| Operating expense | — | — |
| Net income | 37.41M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AUPH returned +35.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +4.4% |
| 1 year | +35.7% |
| 5 years | +2.3% |
| 10 years | +758.2% |
| All-time high | $33.08 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AUPH would be worth today ›No. Aurinia Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
Aurinia Pharmaceuticals Inc. stock trades on NASDAQ under the ticker symbol AUPH.
Aurinia Pharmaceuticals Inc. is part of the Healthcare sector.
Aurinia Pharmaceuticals Inc. has a market cap of 2.22B USD, based on the latest quote.
